WEBVTT Kind: captions Language: en Style: ::cue(c.colorCCCCCC) { color: rgb(204,204,204); } ::cue(c.colorE5E5E5) { color: rgb(229,229,229); } ## 00:00:01.540 --> 00:00:08.259 align:start position:0% [Music] 00:00:08.259 --> 00:00:08.269 align:start position:0% [Music] 00:00:08.269 --> 00:00:10.430 align:start position:0% [Music] welcome<00:00:09.269> to<00:00:09.480> the<00:00:09.570> daily<00:00:09.719> highlights<00:00:09.929> videos 00:00:10.430 --> 00:00:10.440 align:start position:0% welcome to the daily highlights videos 00:00:10.440 --> 00:00:13.190 align:start position:0% welcome to the daily highlights videos from<00:00:10.740> the<00:00:10.950> ers<00:00:11.519> my<00:00:12.240> name<00:00:12.389> is<00:00:12.509> Neil<00:00:12.660> Martin<00:00:12.900> I'm 00:00:13.190 --> 00:00:13.200 align:start position:0% from the ers my name is Neil Martin I'm 00:00:13.200 --> 00:00:14.959 align:start position:0% from the ers my name is Neil Martin I'm one<00:00:13.380> of<00:00:13.500> the<00:00:13.620> global<00:00:13.889> medical<00:00:14.280> experts<00:00:14.759> who 00:00:14.959 --> 00:00:14.969 align:start position:0% one of the global medical experts who 00:00:14.969 --> 00:00:18.080 align:start position:0% one of the global medical experts who works<00:00:15.150> for<00:00:15.330> GSK<00:00:15.780> and<00:00:16.049> I'm<00:00:16.470> joined<00:00:16.740> by<00:00:17.130> today 00:00:18.080 --> 00:00:18.090 align:start position:0% works for GSK and I'm joined by today 00:00:18.090 --> 00:00:19.519 align:start position:0% works for GSK and I'm joined by today but<00:00:18.300> with<00:00:18.449> my<00:00:18.570> colleague<00:00:18.900> Emilio<00:00:19.380> please 00:00:19.519 --> 00:00:19.529 align:start position:0% but with my colleague Emilio please 00:00:19.529 --> 00:00:22.000 align:start position:0% but with my colleague Emilio please zucchini<00:00:19.920> one<00:00:20.400> of<00:00:20.490> our<00:00:20.609> Jimmy's<00:00:21.029> from<00:00:21.330> Brazil 00:00:22.000 --> 00:00:22.010 align:start position:0% zucchini one of our Jimmy's from Brazil 00:00:22.010 --> 00:00:24.830 align:start position:0% zucchini one of our Jimmy's from Brazil we<00:00:23.010> both<00:00:23.189> went<00:00:23.400> to<00:00:23.730> a<00:00:24.029> lunchtime<00:00:24.390> session 00:00:24.830 --> 00:00:24.840 align:start position:0% we both went to a lunchtime session 00:00:24.840 --> 00:00:27.290 align:start position:0% we both went to a lunchtime session today<00:00:25.140> which<00:00:25.470> was<00:00:25.650> run<00:00:25.890> based<00:00:26.640> around<00:00:26.880> new 00:00:27.290 --> 00:00:27.300 align:start position:0% today which was run based around new 00:00:27.300 --> 00:00:29.540 align:start position:0% today which was run based around new biologic<00:00:27.840> agents<00:00:28.320> for<00:00:28.560> severe<00:00:28.830> asthma 00:00:29.540 --> 00:00:29.550 align:start position:0% biologic agents for severe asthma 00:00:29.550 --> 00:00:30.890 align:start position:0% biologic agents for severe asthma I<00:00:29.580> mean<00:00:30.330> though<00:00:30.449> there<00:00:30.570> was<00:00:30.660> a<00:00:30.689> lot<00:00:30.750> of 00:00:30.890 --> 00:00:30.900 align:start position:0% I mean though there was a lot of 00:00:30.900 --> 00:00:33.520 align:start position:0% I mean though there was a lot of discussion<00:00:31.590> and<00:00:31.769> the<00:00:32.239> seminar<00:00:33.239> today 00:00:33.520 --> 00:00:33.530 align:start position:0% discussion and the seminar today 00:00:33.530 --> 00:00:36.590 align:start position:0% discussion and the seminar today starting<00:00:34.530> with<00:00:34.559> Sally<00:00:35.190> Wenzel<00:00:35.640> who<00:00:36.390> went 00:00:36.590 --> 00:00:36.600 align:start position:0% starting with Sally Wenzel who went 00:00:36.600 --> 00:00:38.389 align:start position:0% starting with Sally Wenzel who went through<00:00:36.719> then<00:00:37.079> an<00:00:37.230> overview<00:00:37.649> of<00:00:37.739> the<00:00:37.860> biology 00:00:38.389 --> 00:00:38.399 align:start position:0% through then an overview of the biology 00:00:38.399 --> 00:00:40.430 align:start position:0% through then an overview of the biology of<00:00:38.430> all<00:00:38.700> the<00:00:38.820> different<00:00:39.090> biologic<00:00:39.570> agents<00:00:39.960> and 00:00:40.430 --> 00:00:40.440 align:start position:0% of all the different biologic agents and 00:00:40.440 --> 00:00:41.690 align:start position:0% of all the different biologic agents and one<00:00:40.770> of<00:00:40.829> the<00:00:40.890> things<00:00:41.010> that<00:00:41.100> really<00:00:41.160> stood<00:00:41.550> out 00:00:41.690 --> 00:00:41.700 align:start position:0% one of the things that really stood out 00:00:41.700 --> 00:00:44.209 align:start position:0% one of the things that really stood out to<00:00:41.879> me<00:00:41.910> was<00:00:42.210> the<00:00:42.239> importance<00:00:43.050> of<00:00:43.170> the<00:00:43.680> presence 00:00:44.209 --> 00:00:44.219 align:start position:0% to me was the importance of the presence 00:00:44.219 --> 00:00:45.650 align:start position:0% to me was the importance of the presence or<00:00:44.309> absence<00:00:44.489> of<00:00:44.879> ES<00:00:45.180> and<00:00:45.239> a<00:00:45.390> filling 00:00:45.650 --> 00:00:45.660 align:start position:0% or absence of ES and a filling 00:00:45.660 --> 00:00:48.979 align:start position:0% or absence of ES and a filling inflammation<00:00:46.320> in<00:00:46.980> severe<00:00:47.789> asthma<00:00:48.210> what<00:00:48.870> was 00:00:48.979 --> 00:00:48.989 align:start position:0% inflammation in severe asthma what was 00:00:48.989 --> 00:00:52.510 align:start position:0% inflammation in severe asthma what was your<00:00:49.110> take<00:00:49.320> on<00:00:49.500> that<00:00:49.680> well<00:00:49.950> I<00:00:50.910> think<00:00:51.180> sister 00:00:52.510 --> 00:00:52.520 align:start position:0% your take on that well I think sister 00:00:52.520 --> 00:00:54.889 align:start position:0% your take on that well I think sister the<00:00:53.520> research<00:00:54.149> that<00:00:54.180> start<00:00:54.809> with 00:00:54.889 --> 00:00:54.899 align:start position:0% the research that start with 00:00:54.899 --> 00:00:57.770 align:start position:0% the research that start with bronchoscopy<00:00:55.829> and<00:00:56.670> this<00:00:57.300> has<00:00:57.539> been 00:00:57.770 --> 00:00:57.780 align:start position:0% bronchoscopy and this has been 00:00:57.780 --> 00:01:00.560 align:start position:0% bronchoscopy and this has been highlighted<00:00:58.440> in<00:00:59.039> the<00:00:59.190> meeting<00:00:59.520> that<00:00:59.730> we 00:01:00.560 --> 00:01:00.570 align:start position:0% highlighted in the meeting that we 00:01:00.570 --> 00:01:04.009 align:start position:0% highlighted in the meeting that we understood<00:01:01.320> that<00:01:01.579> asthma<00:01:02.579> is<00:01:03.019> heterogeneous 00:01:04.009 --> 00:01:04.019 align:start position:0% understood that asthma is heterogeneous 00:01:04.019 --> 00:01:07.070 align:start position:0% understood that asthma is heterogeneous disease<00:01:04.400> some<00:01:05.400> patients<00:01:05.909> have<00:01:06.060> asthma<00:01:06.810> that 00:01:07.070 --> 00:01:07.080 align:start position:0% disease some patients have asthma that 00:01:07.080 --> 00:01:10.130 align:start position:0% disease some patients have asthma that is<00:01:07.439> rich<00:01:07.740> in<00:01:08.040> the<00:01:08.250> original<00:01:08.549> field<00:01:08.820> aged<00:01:09.299> too 00:01:10.130 --> 00:01:10.140 align:start position:0% is rich in the original field aged too 00:01:10.140 --> 00:01:12.560 align:start position:0% is rich in the original field aged too high<00:01:10.439> and<00:01:10.770> some<00:01:11.430> patients<00:01:11.820> have<00:01:11.939> an<00:01:12.180> asthma 00:01:12.560 --> 00:01:12.570 align:start position:0% high and some patients have an asthma 00:01:12.570 --> 00:01:14.390 align:start position:0% high and some patients have an asthma that<00:01:12.750> does<00:01:13.080> not<00:01:13.320> have<00:01:13.619> the<00:01:13.860> zeal<00:01:14.070> of<00:01:14.159> yours 00:01:14.390 --> 00:01:14.400 align:start position:0% that does not have the zeal of yours 00:01:14.400 --> 00:01:17.899 align:start position:0% that does not have the zeal of yours what<00:01:15.360> you<00:01:15.570> have<00:01:15.750> understood<00:01:16.320> also<00:01:16.619> that<00:01:17.100> there 00:01:17.899 --> 00:01:17.909 align:start position:0% what you have understood also that there 00:01:17.909 --> 00:01:19.609 align:start position:0% what you have understood also that there are<00:01:18.030> critical<00:01:18.479> characters<00:01:18.990> that<00:01:19.320> may 00:01:19.609 --> 00:01:19.619 align:start position:0% are critical characters that may 00:01:19.619 --> 00:01:21.260 align:start position:0% are critical characters that may differentiate<00:01:20.070> those<00:01:20.580> in<00:01:20.759> the<00:01:20.850> physical 00:01:21.260 --> 00:01:21.270 align:start position:0% differentiate those in the physical 00:01:21.270 --> 00:01:24.770 align:start position:0% differentiate those in the physical model<00:01:21.600> to<00:01:21.780> the<00:01:21.900> FIDIC<00:01:22.170> asthma<00:01:22.590> but<00:01:23.040> mostly<00:01:23.780> we 00:01:24.770 --> 00:01:24.780 align:start position:0% model to the FIDIC asthma but mostly we 00:01:24.780 --> 00:01:27.350 align:start position:0% model to the FIDIC asthma but mostly we need<00:01:25.020> to<00:01:25.140> use<00:01:25.350> a<00:01:25.380> biomarker<00:01:25.979> to<00:01:26.340> predict<00:01:26.759> to 00:01:27.350 --> 00:01:27.360 align:start position:0% need to use a biomarker to predict to 00:01:27.360 --> 00:01:30.380 align:start position:0% need to use a biomarker to predict to understand<00:01:28.130> what<00:01:29.130> kind<00:01:29.610> of<00:01:29.790> asthma<00:01:30.210> those 00:01:30.380 --> 00:01:30.390 align:start position:0% understand what kind of asthma those 00:01:30.390 --> 00:01:33.679 align:start position:0% understand what kind of asthma those patients<00:01:30.900> have<00:01:31.310> the<00:01:32.310> biomarkers<00:01:33.270> that<00:01:33.450> have 00:01:33.679 --> 00:01:33.689 align:start position:0% patients have the biomarkers that have 00:01:33.689 --> 00:01:36.170 align:start position:0% patients have the biomarkers that have been<00:01:33.900> spoken<00:01:34.259> about<00:01:34.560> where<00:01:35.189> you<00:01:35.430> know<00:01:35.790> fuse 00:01:36.170 --> 00:01:36.180 align:start position:0% been spoken about where you know fuse 00:01:36.180 --> 00:01:39.190 align:start position:0% been spoken about where you know fuse fuse<00:01:36.450> oh<00:01:36.659> and<00:01:36.900> blood<00:01:37.340> Perry<00:01:38.340> Austin<00:01:38.820> and 00:01:39.190 --> 00:01:39.200 align:start position:0% fuse oh and blood Perry Austin and 00:01:39.200 --> 00:01:43.219 align:start position:0% fuse oh and blood Perry Austin and phenyl<00:01:40.490> and<00:01:41.490> so<00:01:42.270> Elizabeth<00:01:42.630> Bell<00:01:42.810> then<00:01:43.020> gave 00:01:43.219 --> 00:01:43.229 align:start position:0% phenyl and so Elizabeth Bell then gave 00:01:43.229 --> 00:01:45.109 align:start position:0% phenyl and so Elizabeth Bell then gave the<00:01:43.380> second<00:01:43.799> table<00:01:44.009> looking<00:01:44.820> at<00:01:45.000> the 00:01:45.109 --> 00:01:45.119 align:start position:0% the second table looking at the 00:01:45.119 --> 00:01:47.630 align:start position:0% the second table looking at the translational<00:01:46.020> science<00:01:46.560> so<00:01:47.280> we<00:01:47.399> have<00:01:47.520> this 00:01:47.630 --> 00:01:47.640 align:start position:0% translational science so we have this 00:01:47.640 --> 00:01:50.510 align:start position:0% translational science so we have this range<00:01:47.970> of<00:01:48.270> biomarkers<00:01:48.990> which<00:01:49.200> indicate<00:01:50.009> th2 00:01:50.510 --> 00:01:50.520 align:start position:0% range of biomarkers which indicate th2 00:01:50.520 --> 00:01:52.760 align:start position:0% range of biomarkers which indicate th2 high<00:01:50.700> disease<00:01:51.030> as<00:01:51.180> you<00:01:51.210> say<00:01:51.479> but<00:01:52.229> it<00:01:52.320> was<00:01:52.470> clear 00:01:52.760 --> 00:01:52.770 align:start position:0% high disease as you say but it was clear 00:01:52.770 --> 00:01:55.399 align:start position:0% high disease as you say but it was clear that<00:01:52.799> the<00:01:53.250> presence<00:01:54.060> or<00:01:54.149> absence<00:01:54.299> of<00:01:54.810> a<00:01:55.170> high 00:01:55.399 --> 00:01:55.409 align:start position:0% that the presence or absence of a high 00:01:55.409 --> 00:01:58.069 align:start position:0% that the presence or absence of a high blood<00:01:55.829> is<00:01:56.100> of<00:01:56.369> a<00:01:56.490> kind<00:01:56.729> seemed<00:01:57.450> to<00:01:57.659> determine 00:01:58.069 --> 00:01:58.079 align:start position:0% blood is of a kind seemed to determine 00:01:58.079 --> 00:01:59.300 align:start position:0% blood is of a kind seemed to determine response<00:01:58.409> to<00:01:58.560> therapy<00:01:58.710> in<00:01:58.920> other<00:01:59.009> words<00:01:59.159> it 00:01:59.300 --> 00:01:59.310 align:start position:0% response to therapy in other words it 00:01:59.310 --> 00:02:01.429 align:start position:0% response to therapy in other words it was<00:01:59.430> a<00:01:59.460> predictive<00:02:00.090> biomarker<00:02:00.810> for<00:02:00.990> these 00:02:01.429 --> 00:02:01.439 align:start position:0% was a predictive biomarker for these 00:02:01.439 --> 00:02:04.039 align:start position:0% was a predictive biomarker for these patients<00:02:01.619> responding<00:02:02.250> to<00:02:02.340> biologics<00:02:03.049> yet 00:02:04.039 --> 00:02:04.049 align:start position:0% patients responding to biologics yet 00:02:04.049 --> 00:02:05.990 align:start position:0% patients responding to biologics yet understand<00:02:04.710> the<00:02:04.770> road<00:02:05.040> about<00:02:05.369> civilians<00:02:05.880> in 00:02:05.990 --> 00:02:06.000 align:start position:0% understand the road about civilians in 00:02:06.000 --> 00:02:07.459 align:start position:0% understand the road about civilians in the<00:02:06.119> field<00:02:06.299> chiasma<00:02:06.780> it's<00:02:06.960> mainly<00:02:07.290> about 00:02:07.459 --> 00:02:07.469 align:start position:0% the field chiasma it's mainly about 00:02:07.469 --> 00:02:09.199 align:start position:0% the field chiasma it's mainly about understanding<00:02:08.429> the<00:02:08.550> role<00:02:08.700> of<00:02:08.729> blood 00:02:09.199 --> 00:02:09.209 align:start position:0% understanding the role of blood 00:02:09.209 --> 00:02:11.570 align:start position:0% understanding the role of blood eosinophils<00:02:09.929> our<00:02:10.110> biomarker<00:02:10.890> in<00:02:11.489> the 00:02:11.570 --> 00:02:11.580 align:start position:0% eosinophils our biomarker in the 00:02:11.580 --> 00:02:13.320 align:start position:0% eosinophils our biomarker in the beginning<00:02:11.910> that<00:02:12.150> was<00:02:12.360> not 00:02:13.320 --> 00:02:13.330 align:start position:0% beginning that was not 00:02:13.330 --> 00:02:15.300 align:start position:0% beginning that was not the<00:02:13.420> road<00:02:13.660> that<00:02:13.870> was<00:02:14.080> choosing<00:02:14.560> foremost<00:02:15.070> at 00:02:15.300 --> 00:02:15.310 align:start position:0% the road that was choosing foremost at 00:02:15.310 --> 00:02:17.940 align:start position:0% the road that was choosing foremost at pharmaceutical<00:02:16.060> companies<00:02:16.480> to<00:02:16.950> understand 00:02:17.940 --> 00:02:17.950 align:start position:0% pharmaceutical companies to understand 00:02:17.950 --> 00:02:19.740 align:start position:0% pharmaceutical companies to understand that<00:02:18.160> at<00:02:18.370> the<00:02:18.400> response<00:02:18.910> to<00:02:19.030> treatment<00:02:19.480> but 00:02:19.740 --> 00:02:19.750 align:start position:0% that at the response to treatment but 00:02:19.750 --> 00:02:22.590 align:start position:0% that at the response to treatment but later<00:02:20.050> on<00:02:20.250> parasitical<00:02:21.250> companies<00:02:21.700> develop 00:02:22.590 --> 00:02:22.600 align:start position:0% later on parasitical companies develop 00:02:22.600 --> 00:02:26.010 align:start position:0% later on parasitical companies develop in<00:02:22.750> New<00:02:22.990> England<00:02:23.290> biological<00:02:24.270> choose<00:02:25.270> body 00:02:26.010 --> 00:02:26.020 align:start position:0% in New England biological choose body 00:02:26.020 --> 00:02:28.530 align:start position:0% in New England biological choose body asana<00:02:26.350> fuels<00:02:26.590> has<00:02:27.130> been<00:02:27.400> made<00:02:27.640> biomarker<00:02:28.390> to 00:02:28.530 --> 00:02:28.540 align:start position:0% asana fuels has been made biomarker to 00:02:28.540 --> 00:02:30.780 align:start position:0% asana fuels has been made biomarker to follow<00:02:28.810> those<00:02:29.050> patients<00:02:29.260> and<00:02:30.040> then<00:02:30.670> it 00:02:30.780 --> 00:02:30.790 align:start position:0% follow those patients and then it 00:02:30.790 --> 00:02:33.480 align:start position:0% follow those patients and then it becomes<00:02:31.120> a<00:02:31.390> challenge<00:02:31.720> because<00:02:32.110> we<00:02:32.350> have<00:02:33.040> one 00:02:33.480 --> 00:02:33.490 align:start position:0% becomes a challenge because we have one 00:02:33.490 --> 00:02:36.630 align:start position:0% becomes a challenge because we have one biomarker<00:02:34.090> which<00:02:35.040> predicts<00:02:36.040> responds<00:02:36.490> to 00:02:36.630 --> 00:02:36.640 align:start position:0% biomarker which predicts responds to 00:02:36.640 --> 00:02:38.220 align:start position:0% biomarker which predicts responds to many<00:02:36.820> different<00:02:37.000> drugs<00:02:37.390> and<00:02:37.660> roland<00:02:38.080> bull 00:02:38.220 --> 00:02:38.230 align:start position:0% many different drugs and roland bull 00:02:38.230 --> 00:02:40.500 align:start position:0% many different drugs and roland bull from<00:02:38.530> germany<00:02:38.890> then<00:02:39.150> gave<00:02:40.150> us<00:02:40.270> a<00:02:40.360> little 00:02:40.500 --> 00:02:40.510 align:start position:0% from germany then gave us a little 00:02:40.510 --> 00:02:42.120 align:start position:0% from germany then gave us a little rundown<00:02:40.750> of<00:02:41.020> how<00:02:41.230> they<00:02:41.470> look<00:02:41.680> in<00:02:41.800> clinical 00:02:42.120 --> 00:02:42.130 align:start position:0% rundown of how they look in clinical 00:02:42.130 --> 00:02:43.500 align:start position:0% rundown of how they look in clinical practice<00:02:42.160> to<00:02:42.520> try<00:02:42.820> and<00:02:42.940> work<00:02:43.060> out<00:02:43.240> which 00:02:43.500 --> 00:02:43.510 align:start position:0% practice to try and work out which 00:02:43.510 --> 00:02:45.780 align:start position:0% practice to try and work out which patient<00:02:43.960> for<00:02:44.110> which<00:02:44.260> medicine<00:02:44.710> and<00:02:45.160> it<00:02:45.550> became 00:02:45.780 --> 00:02:45.790 align:start position:0% patient for which medicine and it became 00:02:45.790 --> 00:02:47.520 align:start position:0% patient for which medicine and it became obvious<00:02:45.940> it<00:02:46.210> was<00:02:46.330> quite<00:02:46.570> difficult<00:02:46.810> and<00:02:47.380> there 00:02:47.520 --> 00:02:47.530 align:start position:0% obvious it was quite difficult and there 00:02:47.530 --> 00:02:50.610 align:start position:0% obvious it was quite difficult and there was<00:02:47.620> a<00:02:47.650> call<00:02:47.950> for<00:02:48.280> some<00:02:48.570> way<00:02:49.570> forward<00:02:50.230> of<00:02:50.440> how 00:02:50.610 --> 00:02:50.620 align:start position:0% was a call for some way forward of how 00:02:50.620 --> 00:02:52.680 align:start position:0% was a call for some way forward of how we<00:02:50.680> do<00:02:50.920> this<00:02:50.950> and<00:02:51.370> pragmatic<00:02:52.060> randomized 00:02:52.680 --> 00:02:52.690 align:start position:0% we do this and pragmatic randomized 00:02:52.690 --> 00:02:54.210 align:start position:0% we do this and pragmatic randomized controlled<00:02:53.140> trials<00:02:53.530> how<00:02:53.650> do<00:02:53.710> you<00:02:53.830> think<00:02:54.040> we're 00:02:54.210 --> 00:02:54.220 align:start position:0% controlled trials how do you think we're 00:02:54.220 --> 00:02:56.250 align:start position:0% controlled trials how do you think we're going<00:02:54.370> to<00:02:54.460> do<00:02:54.670> this<00:02:54.820> going<00:02:55.060> forward<00:02:55.360> yeah<00:02:56.080> the 00:02:56.250 --> 00:02:56.260 align:start position:0% going to do this going forward yeah the 00:02:56.260 --> 00:02:58.920 align:start position:0% going to do this going forward yeah the reason<00:02:56.470> for<00:02:57.160> this<00:02:57.340> is<00:02:57.400> we<00:02:58.120> don't<00:02:58.330> have<00:02:58.660> direct 00:02:58.920 --> 00:02:58.930 align:start position:0% reason for this is we don't have direct 00:02:58.930 --> 00:03:01.680 align:start position:0% reason for this is we don't have direct comparison<00:02:59.830> between<00:02:59.860> all<00:03:00.790> the<00:03:01.180> treatment 00:03:01.680 --> 00:03:01.690 align:start position:0% comparison between all the treatment 00:03:01.690 --> 00:03:04.100 align:start position:0% comparison between all the treatment drugs<00:03:01.960> that<00:03:02.170> we<00:03:02.320> have<00:03:02.350> for<00:03:02.740> severe<00:03:03.070> asthma 00:03:04.100 --> 00:03:04.110 align:start position:0% drugs that we have for severe asthma 00:03:04.110 --> 00:03:07.980 align:start position:0% drugs that we have for severe asthma however<00:03:05.110> we<00:03:05.380> have<00:03:06.360> meta-analysis<00:03:07.360> and<00:03:07.510> some 00:03:07.980 --> 00:03:07.990 align:start position:0% however we have meta-analysis and some 00:03:07.990 --> 00:03:09.360 align:start position:0% however we have meta-analysis and some methanol's<00:03:08.500> have<00:03:08.710> been<00:03:08.890> published<00:03:09.280> in<00:03:09.310> the 00:03:09.360 --> 00:03:09.370 align:start position:0% methanol's have been published in the 00:03:09.370 --> 00:03:11.700 align:start position:0% methanol's have been published in the past<00:03:09.490> the<00:03:09.970> cochrane<00:03:10.330> mainly<00:03:10.750> showed<00:03:11.440> that 00:03:11.700 --> 00:03:11.710 align:start position:0% past the cochrane mainly showed that 00:03:11.710 --> 00:03:12.660 align:start position:0% past the cochrane mainly showed that there<00:03:11.890> was<00:03:12.040> no<00:03:12.220> difference<00:03:12.430> between 00:03:12.660 --> 00:03:12.670 align:start position:0% there was no difference between 00:03:12.670 --> 00:03:15.120 align:start position:0% there was no difference between treatments<00:03:13.570> but<00:03:13.810> they<00:03:13.990> recommend<00:03:14.590> in<00:03:14.740> in<00:03:14.980> the 00:03:15.120 --> 00:03:15.130 align:start position:0% treatments but they recommend in in the 00:03:15.130 --> 00:03:17.910 align:start position:0% treatments but they recommend in in the end<00:03:15.280> that<00:03:16.000> a<00:03:16.390> network<00:03:16.990> meta<00:03:17.230> knowledge<00:03:17.620> could 00:03:17.910 --> 00:03:17.920 align:start position:0% end that a network meta knowledge could 00:03:17.920 --> 00:03:21.300 align:start position:0% end that a network meta knowledge could give<00:03:18.280> us<00:03:18.459> better<00:03:19.120> answer<00:03:19.810> and<00:03:20.050> it<00:03:20.890> has<00:03:21.130> been 00:03:21.300 --> 00:03:21.310 align:start position:0% give us better answer and it has been 00:03:21.310 --> 00:03:23.580 align:start position:0% give us better answer and it has been published<00:03:21.489> during<00:03:21.970> this<00:03:22.239> week<00:03:22.510> paper<00:03:23.230> in<00:03:23.470> de 00:03:23.580 --> 00:03:23.590 align:start position:0% published during this week paper in de 00:03:23.590 --> 00:03:24.000 align:start position:0% published during this week paper in de jakke 00:03:24.000 --> 00:03:24.010 align:start position:0% jakke 00:03:24.010 --> 00:03:26.760 align:start position:0% jakke we're<00:03:24.550> a<00:03:24.580> network<00:03:25.060> metallized<00:03:25.930> was<00:03:26.260> perform 00:03:26.760 --> 00:03:26.770 align:start position:0% we're a network metallized was perform 00:03:26.770 --> 00:03:29.690 align:start position:0% we're a network metallized was perform at<00:03:26.950> and<00:03:27.690> comparison<00:03:28.690> were<00:03:28.840> made<00:03:29.080> between 00:03:29.690 --> 00:03:29.700 align:start position:0% at and comparison were made between 00:03:29.700 --> 00:03:33.030 align:start position:0% at and comparison were made between subjects<00:03:30.700> that<00:03:30.820> they<00:03:31.060> looked<00:03:31.600> alike<00:03:32.110> in 00:03:33.030 --> 00:03:33.040 align:start position:0% subjects that they looked alike in 00:03:33.040 --> 00:03:35.610 align:start position:0% subjects that they looked alike in relation<00:03:33.730> to<00:03:33.760> do<00:03:34.090> synthetic<00:03:34.420> inflammation<00:03:35.320> of 00:03:35.610 --> 00:03:35.620 align:start position:0% relation to do synthetic inflammation of 00:03:35.620 --> 00:03:38.460 align:start position:0% relation to do synthetic inflammation of the<00:03:35.680> airways<00:03:36.340> and<00:03:36.580> the<00:03:37.000> lack<00:03:37.630> of<00:03:37.660> the<00:03:38.020> control 00:03:38.460 --> 00:03:38.470 align:start position:0% the airways and the lack of the control 00:03:38.470 --> 00:03:42.630 align:start position:0% the airways and the lack of the control and<00:03:38.950> when<00:03:39.580> we<00:03:39.760> use<00:03:40.000> those<00:03:40.360> elements<00:03:41.459> we<00:03:42.459> can 00:03:42.630 --> 00:03:42.640 align:start position:0% and when we use those elements we can 00:03:42.640 --> 00:03:44.670 align:start position:0% and when we use those elements we can see<00:03:42.910> that<00:03:43.090> response<00:03:43.660> to<00:03:43.840> maple<00:03:44.140> is<00:03:44.260> Uma<00:03:44.470> is 00:03:44.670 --> 00:03:44.680 align:start position:0% see that response to maple is Uma is 00:03:44.680 --> 00:03:47.430 align:start position:0% see that response to maple is Uma is better<00:03:45.370> for<00:03:45.700> acceleration<00:03:46.239> reduction<00:03:46.989> in 00:03:47.430 --> 00:03:47.440 align:start position:0% better for acceleration reduction in 00:03:47.440 --> 00:03:50.820 align:start position:0% better for acceleration reduction in relation<00:03:47.980> to<00:03:48.010> the<00:03:48.250> other<00:03:48.400> two<00:03:49.360> components<00:03:49.989> and 00:03:50.820 --> 00:03:50.830 align:start position:0% relation to the other two components and 00:03:50.830 --> 00:03:53.010 align:start position:0% relation to the other two components and and<00:03:51.280> and<00:03:51.550> you're<00:03:52.239> obviously<00:03:52.360> right<00:03:52.690> so<00:03:52.900> we 00:03:53.010 --> 00:03:53.020 align:start position:0% and and you're obviously right so we 00:03:53.020 --> 00:03:55.110 align:start position:0% and and you're obviously right so we have<00:03:53.170> this<00:03:53.320> network<00:03:53.650> meta-analysis<00:03:54.520> but<00:03:55.000> the 00:03:55.110 --> 00:03:55.120 align:start position:0% have this network meta-analysis but the 00:03:55.120 --> 00:03:57.120 align:start position:0% have this network meta-analysis but the call<00:03:55.420> and<00:03:55.780> the<00:03:55.870> idea<00:03:56.200> of<00:03:56.260> this<00:03:56.380> symposium<00:03:56.709> came 00:03:57.120 --> 00:03:57.130 align:start position:0% call and the idea of this symposium came 00:03:57.130 --> 00:03:58.979 align:start position:0% call and the idea of this symposium came from<00:03:57.310> jeff<00:03:57.610> Drazen<00:03:58.060> from<00:03:58.540> the<00:03:58.690> New<00:03:58.780> England 00:03:58.979 --> 00:03:58.989 align:start position:0% from jeff Drazen from the New England 00:03:58.989 --> 00:04:00.449 align:start position:0% from jeff Drazen from the New England Journal<00:03:59.050> of<00:03:59.200> Medicine<00:03:59.290> an<00:03:59.950> editorial 00:04:00.449 --> 00:04:00.459 align:start position:0% Journal of Medicine an editorial 00:04:00.459 --> 00:04:01.979 align:start position:0% Journal of Medicine an editorial published<00:04:00.790> there<00:04:01.090> recently<00:04:01.510> saying<00:04:01.780> that 00:04:01.979 --> 00:04:01.989 align:start position:0% published there recently saying that 00:04:01.989 --> 00:04:04.710 align:start position:0% published there recently saying that what<00:04:02.230> we<00:04:02.260> as<00:04:02.500> clinicians<00:04:02.650> need<00:04:03.489> to<00:04:03.610> do<00:04:03.760> is<00:04:04.270> have 00:04:04.710 --> 00:04:04.720 align:start position:0% what we as clinicians need to do is have 00:04:04.720 --> 00:04:07.650 align:start position:0% what we as clinicians need to do is have a<00:04:05.080> pragmatic<00:04:05.770> head-to-head<00:04:06.400> trials<00:04:06.820> can<00:04:07.540> you 00:04:07.650 --> 00:04:07.660 align:start position:0% a pragmatic head-to-head trials can you 00:04:07.660 --> 00:04:10.770 align:start position:0% a pragmatic head-to-head trials can you see<00:04:07.810> those<00:04:07.959> happening<00:04:08.410> soon<00:04:08.680> I<00:04:08.920> don't<00:04:09.780> like 00:04:10.770 --> 00:04:10.780 align:start position:0% see those happening soon I don't like 00:04:10.780 --> 00:04:12.120 align:start position:0% see those happening soon I don't like the<00:04:10.900> difficult<00:04:11.290> thing<00:04:11.440> isn't<00:04:11.650> it<00:04:11.769> to<00:04:11.860> do<00:04:11.980> those 00:04:12.120 --> 00:04:12.130 align:start position:0% the difficult thing isn't it to do those 00:04:12.130 --> 00:04:15.150 align:start position:0% the difficult thing isn't it to do those things<00:04:12.660> the<00:04:13.660> final<00:04:14.080> thing<00:04:14.350> that<00:04:14.620> happened 00:04:15.150 --> 00:04:15.160 align:start position:0% things the final thing that happened 00:04:15.160 --> 00:04:17.280 align:start position:0% things the final thing that happened during<00:04:15.250> the<00:04:15.670> symposium<00:04:16.239> was<00:04:16.660> that<00:04:16.989> one<00:04:17.169> of 00:04:17.280 --> 00:04:17.290 align:start position:0% during the symposium was that one of 00:04:17.290 --> 00:04:20.909 align:start position:0% during the symposium was that one of Elizabeth<00:04:17.650> Bell's<00:04:17.859> patients<00:04:19.590> came<00:04:20.590> on<00:04:20.739> stage 00:04:20.909 --> 00:04:20.919 align:start position:0% Elizabeth Bell's patients came on stage 00:04:20.919 --> 00:04:23.370 align:start position:0% Elizabeth Bell's patients came on stage very<00:04:21.250> bravely<00:04:21.549> to<00:04:21.910> speak<00:04:22.090> in<00:04:22.210> English<00:04:22.350> as<00:04:23.350> a 00:04:23.370 --> 00:04:23.380 align:start position:0% very bravely to speak in English as a 00:04:23.380 --> 00:04:26.370 align:start position:0% very bravely to speak in English as a Dutch<00:04:23.650> patient<00:04:24.039> and<00:04:24.390> was<00:04:25.390> really<00:04:25.630> giving<00:04:26.289> us 00:04:26.370 --> 00:04:26.380 align:start position:0% Dutch patient and was really giving us 00:04:26.380 --> 00:04:26.940 align:start position:0% Dutch patient and was really giving us an<00:04:26.440> indication 00:04:26.940 --> 00:04:26.950 align:start position:0% an indication 00:04:26.950 --> 00:04:28.590 align:start position:0% an indication what<00:04:27.070> it<00:04:27.160> was<00:04:27.250> like<00:04:27.490> to<00:04:27.760> have<00:04:27.880> severe<00:04:28.180> asthma 00:04:28.590 --> 00:04:28.600 align:start position:0% what it was like to have severe asthma 00:04:28.600 --> 00:04:30.750 align:start position:0% what it was like to have severe asthma and<00:04:28.780> the<00:04:29.260> impact<00:04:29.680> at<00:04:29.920> being<00:04:30.100> on<00:04:30.190> a<00:04:30.280> biologic 00:04:30.750 --> 00:04:30.760 align:start position:0% and the impact at being on a biologic 00:04:30.760 --> 00:04:32.850 align:start position:0% and the impact at being on a biologic made<00:04:30.910> for<00:04:31.090> him<00:04:31.240> and<00:04:31.690> Jeff<00:04:32.080> Jason<00:04:32.410> asked<00:04:32.770> him 00:04:32.850 --> 00:04:32.860 align:start position:0% made for him and Jeff Jason asked him 00:04:32.860 --> 00:04:36.470 align:start position:0% made for him and Jeff Jason asked him one<00:04:33.580> question<00:04:33.610> what<00:04:34.210> was<00:04:34.330> the<00:04:34.360> one<00:04:34.690> thing<00:04:34.720> that 00:04:36.470 --> 00:04:36.480 align:start position:0% one question what was the one thing that 00:04:36.480 --> 00:04:40.170 align:start position:0% one question what was the one thing that improves<00:04:37.480> and<00:04:37.890> you<00:04:38.890> know<00:04:38.950> III<00:04:39.310> was<00:04:39.820> very<00:04:40.000> moved 00:04:40.170 --> 00:04:40.180 align:start position:0% improves and you know III was very moved 00:04:40.180 --> 00:04:43.200 align:start position:0% improves and you know III was very moved by<00:04:40.210> yeah<00:04:40.480> yeah<00:04:40.870> so<00:04:41.800> in<00:04:42.310> the<00:04:42.490> beginning<00:04:42.640> the<00:04:43.180> the 00:04:43.200 --> 00:04:43.210 align:start position:0% by yeah yeah so in the beginning the the 00:04:43.210 --> 00:04:45.690 align:start position:0% by yeah yeah so in the beginning the the speakers<00:04:44.170> were<00:04:44.350> speaking<00:04:45.130> about<00:04:45.370> the 00:04:45.690 --> 00:04:45.700 align:start position:0% speakers were speaking about the 00:04:45.700 --> 00:04:48.600 align:start position:0% speakers were speaking about the importance<00:04:46.150> of<00:04:46.330> prednisone<00:04:47.430> dependence<00:04:48.430> and 00:04:48.600 --> 00:04:48.610 align:start position:0% importance of prednisone dependence and 00:04:48.610 --> 00:04:51.330 align:start position:0% importance of prednisone dependence and the<00:04:48.790> side<00:04:49.000> effects<00:04:49.450> of<00:04:49.570> the<00:04:49.750> drug<00:04:50.040> well<00:04:51.040> and 00:04:51.330 --> 00:04:51.340 align:start position:0% the side effects of the drug well and 00:04:51.340 --> 00:04:54.600 align:start position:0% the side effects of the drug well and turned<00:04:52.300> that<00:04:52.540> was<00:04:52.780> the<00:04:52.900> patient<00:04:53.490> answered<00:04:54.490> the 00:04:54.600 --> 00:04:54.610 align:start position:0% turned that was the patient answered the 00:04:54.610 --> 00:04:56.520 align:start position:0% turned that was the patient answered the question<00:04:54.970> he<00:04:55.060> said<00:04:55.300> what<00:04:55.540> is<00:04:55.720> most<00:04:55.960> important 00:04:56.520 --> 00:04:56.530 align:start position:0% question he said what is most important 00:04:56.530 --> 00:05:00.030 align:start position:0% question he said what is most important is<00:04:56.920> my<00:04:57.160> quality<00:04:57.580> of<00:04:57.670> life<00:04:57.820> I<00:04:58.270> can<00:04:58.660> go<00:04:59.650> up<00:04:59.860> in 00:05:00.030 --> 00:05:00.040 align:start position:0% is my quality of life I can go up in 00:05:00.040 --> 00:05:02.310 align:start position:0% is my quality of life I can go up in stairs<00:05:00.400> if<00:05:00.640> I<00:05:00.760> can<00:05:00.970> live<00:05:01.180> normally<00:05:02.050> she<00:05:02.110> can 00:05:02.310 --> 00:05:02.320 align:start position:0% stairs if I can live normally she can 00:05:02.320 --> 00:05:06.540 align:start position:0% stairs if I can live normally she can stream<00:05:03.300> so<00:05:04.300> much<00:05:04.450> fun<00:05:04.750> yeah<00:05:05.290> and<00:05:05.470> he<00:05:06.190> very 00:05:06.540 --> 00:05:06.550 align:start position:0% stream so much fun yeah and he very 00:05:06.550 --> 00:05:08.520 align:start position:0% stream so much fun yeah and he very clearly<00:05:06.760> put<00:05:06.910> it<00:05:07.150> down<00:05:07.330> to<00:05:07.600> is<00:05:07.750> that<00:05:07.780> they're 00:05:08.520 --> 00:05:08.530 align:start position:0% clearly put it down to is that they're 00:05:08.530 --> 00:05:10.620 align:start position:0% clearly put it down to is that they're not<00:05:08.740> having<00:05:09.280> to<00:05:09.430> think<00:05:09.460> about<00:05:09.970> it<00:05:10.210> so<00:05:10.420> in<00:05:10.540> other 00:05:10.620 --> 00:05:10.630 align:start position:0% not having to think about it so in other 00:05:10.630 --> 00:05:12.600 align:start position:0% not having to think about it so in other words<00:05:10.960> I<00:05:11.260> don't<00:05:11.620> have<00:05:11.800> to<00:05:11.950> what<00:05:12.160> I'm<00:05:12.280> doing 00:05:12.600 --> 00:05:12.610 align:start position:0% words I don't have to what I'm doing 00:05:12.610 --> 00:05:15.000 align:start position:0% words I don't have to what I'm doing anything<00:05:12.790> or<00:05:13.090> I'm<00:05:13.210> traveling<00:05:13.620> about<00:05:14.620> what's 00:05:15.000 --> 00:05:15.010 align:start position:0% anything or I'm traveling about what's 00:05:15.010 --> 00:05:17.010 align:start position:0% anything or I'm traveling about what's going<00:05:15.280> to<00:05:15.310> happen<00:05:15.640> with<00:05:15.760> my<00:05:15.910> severe<00:05:16.210> asthma<00:05:16.510> so 00:05:17.010 --> 00:05:17.020 align:start position:0% going to happen with my severe asthma so 00:05:17.020 --> 00:05:17.970 align:start position:0% going to happen with my severe asthma so thank<00:05:17.140> you<00:05:17.230> very<00:05:17.350> much<00:05:17.500> for<00:05:17.680> joining<00:05:17.860> me 00:05:17.970 --> 00:05:17.980 align:start position:0% thank you very much for joining me 00:05:17.980 --> 00:05:19.560 align:start position:0% thank you very much for joining me Emilio<00:05:18.370> and<00:05:18.580> thank<00:05:19.030> you<00:05:19.120> very<00:05:19.240> much<00:05:19.390> for 00:05:19.560 --> 00:05:19.570 align:start position:0% Emilio and thank you very much for 00:05:19.570 --> 00:05:21.630 align:start position:0% Emilio and thank you very much for joining<00:05:19.600> us<00:05:19.960> for<00:05:20.260> the<00:05:20.410> daily<00:05:20.770> ers<00:05:21.220> highlights 00:05:21.630 --> 00:05:21.640 align:start position:0% joining us for the daily ers highlights 00:05:21.640 --> 00:05:24.720 align:start position:0% joining us for the daily ers highlights video<00:05:21.940> thank<00:05:22.510> you